Windward Bio Group AG (WWB)

Windward Bio Group AG Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024
Operating Income Operating Income Growth	-73.23	-51.83	-1.19
Net Income Net Income Growth	-68.21	-48.32	-1.19

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024
Cash & Investments Cash & Investments Growth	186.47	107.4	0.15
Total Debt Total Debt Growth	0.47	0.31	0
Net Cash (Debt) Net Cash Growth	185.99	107.1	0.15
Net Cash Growth	-	72754.42%	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024
Operating Cash Flow Operating Cash Flow Growth	-49.44	-33.26	-0.07
Capital Expenditures CapEx Growth	-20.58	-25.52	-
Free Cash Flow Free Cash Flow Growth	-70.02	-58.79	-0.07
Free Cash Flow Growth	-	-	-

Data Source: SEC filings Last updated: Jun 30, 2026

The financial data was gathered manually by the Stock Analysis team, from official company filings available on SEC.gov.

Data Sources Report a data error